Sabadell Asabys
Investor profile
Venture capital
Sabadell Asabys has backed 5 European tech companies across 5 funding rounds between 2022 and 2023, joining rounds totalling €65M. Most active in Healthtech. Data as of Nov 2026.
Deals
5
distinct rounds
Companies
5
backed
Active span
2022–2023
2 yrs
Total round €
€65M
sum of rounds joined
Deals by year
distinct rounds / yearSabadell Asabys — deals by year — interactive chart.
Data table
| Sabadell Asabys — deals by year | |
|---|---|
| 2022 | 4 |
| 2023 | 1 |
Top sectors
by dealsSabadell Asabys — top sectors — interactive chart.
Data table
| Sabadell Asabys — top sectors | |
|---|---|
| Healthtech | 5 |
Stages
by dealsSabadell Asabys — stages — interactive chart.
Data table
| Sabadell Asabys — stages | |
|---|---|
| Other | 4 |
| Series B | 1 |
Countries
by dealsSabadell Asabys — countries — interactive chart.
Data table
| Sabadell Asabys — countries | |
|---|---|
| Germany | 2 |
| Spain | 2 |
| Belgium | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Agomab Therapeutics | Belgium | 1 | €41M |
| Cara | Germany | 1 | €7.0M |
| Amelia Virtual Care | Spain | 1 | €7.0M |
| Cara Care | Germany | 1 | €6.6M |
| Deepull | Spain | 1 | €4.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Agomab Therapeutics | Series B | €41M | 2022-07 |
| Cara | Other | €7.0M | 2022-06 |
| Amelia Virtual Care | Other | €7.0M | 2022-06 |
| Cara Care | Other | €6.6M | 2022-06 |
| Deepull | Other | €4.0M | 2023-03 |